Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125161173 | 12516117 | 3 | F | 20160701 | 20160630 | 20160714 | EXP | RU-TEVA-671145ISR | TEVA | 7.00 | MON | F | Y | 0.00000 | 20160714 | CN | RU | RU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125161173 | 12516117 | 1 | PS | Cerucal | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | U | U | 70184 | |||||||||
| 125161173 | 12516117 | 2 | SS | Enterofuryl | NIFUROXAZIDE | 1 | Unknown | U | U | 0 | |||||||||
| 125161173 | 12516117 | 3 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | U | U | 0 | |||||||||
| 125161173 | 12516117 | 4 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | U | 0 | |||||||||
| 125161173 | 12516117 | 5 | SS | Linex | LACTOBACILLUS ACIDOPHILUS | 1 | Unknown | U | U | 0 | |||||||||
| 125161173 | 12516117 | 6 | SS | MOTILIUM | DOMPERIDONE | 1 | Unknown | U | U | 0 | |||||||||
| 125161173 | 12516117 | 7 | SS | Analgin | METAMIZOLE SODIUM | 1 | Unknown | U | U | 0 | |||||||||
| 125161173 | 12516117 | 8 | SS | Dimedrol | DIPHENHYDRAMINE | 1 | Unknown | U | U | 0 | |||||||||
| 125161173 | 12516117 | 9 | SS | MEROPENEM. | MEROPENEM | 1 | Unknown | U | U | 0 | |||||||||
| 125161173 | 12516117 | 10 | SS | Euphyllin | AMINOPHYLLINE | 1 | Unknown | U | U | 0 | |||||||||
| 125161173 | 12516117 | 11 | SS | Viferon | INTERFERON ALFA-2B | 1 | Unknown | U | U | 0 | |||||||||
| 125161173 | 12516117 | 12 | SS | CEFTRIAXONE. | CEFTRIAXONE | 1 | Unknown | U | U | 0 | |||||||||
| 125161173 | 12516117 | 13 | SS | Dexason | DEXAMETHASONE | 1 | Unknown | U | U | 0 | |||||||||
| 125161173 | 12516117 | 14 | SS | Physiological solution | UNSPECIFIED INGREDIENT | 1 | Unknown | U | U | 0 | |||||||||
| 125161173 | 12516117 | 15 | SS | Glucose | DEXTROSE | 1 | Unknown | U | U | 0 | |||||||||
| 125161173 | 12516117 | 16 | SS | VITAMIN C | ASCORBIC ACID | 1 | Unknown | U | U | 0 | |||||||||
| 125161173 | 12516117 | 17 | C | Pantogam | CALCIUM HOPANTENATE | 1 | Unknown | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125161173 | 12516117 | OT |
| 125161173 | 12516117 | DE |
| 125161173 | 12516117 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125161173 | 12516117 | Brain oedema | |
| 125161173 | 12516117 | Central nervous system lesion | |
| 125161173 | 12516117 | Coma | |
| 125161173 | 12516117 | Hepatic failure | |
| 125161173 | 12516117 | Reye's syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |